Clearside Biomedical, Inc. and Santen, Inc. Announce Research Collaboration in Glaucoma

ALPHARETTA, Ga. & EMERYVILLE, Calif.--(BUSINESS WIRE)--Clearside Biomedical, which develops drug therapies to treat eye diseases, and Santen Inc., a Santen Pharmaceuticals Co. subsidiary, will expand their research collaboration to include glaucoma.